Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Catecholamine phenotyping: clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders.

Journal of neurochemistry - 1 Nov 1996

Goldstein D S, Lenders J W, Kaler S G, Eisenhofer G

Abstract excerpt

One purpose of clinical neurochemistry has been to indicate "activities" of catecholamine systems, by assaying levels of the effector compounds or their metabolites in body fluids such as plasma, cerebrospinal fluid, urine, or microdialysate. This review discusses a new purpose: relating specific catecholaminergic phenotypes to neurogenetic disorders. Distinctive catecholamine patterns in several neurogenetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Catecholamines
Share to Dopamine beta-Hydroxylase
Share to Genetic Diseases, Inborn

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Monoamine Oxidase

Share to Nervous System Diseases

Share to Phenotype

Share to Phenylketonurias

Share to Syndrome

Source

Identifiers

PMID: 8863481
DOI: 10.1046/j.1471-4159.1996.67051781.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Catecholamine phenotyping: clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders.PMID 8863481Read ↗

Catecholamine biosynthetic enzyme expression in neurological and psychiatric disorders.Semantic proximity Read ↗

Genetic basis of autonomic dysfunction.Semantic proximity Read ↗

Catecholaminergic pathways, chromaffin cells, and human disease.Semantic proximity Read ↗

Diagnostic approach to neurotransmitter monoamine disorders: experience from clinical, biochemical, and genetic profiles.Semantic proximity Read ↗

Mutations in human monoamine-related neurotransmitter pathway genes.Semantic proximity Read ↗

Catecholamine metabolism: an update on key biosynthetic enzymes and vesicular monoamine transporters.Semantic proximity Read ↗

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.Semantic proximity Read ↗

Clinical implications of genetic and acquired defects in catecholamine synthesis and metabolism.Semantic proximity Read ↗

Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.Semantic proximity Read ↗

Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapySemantic proximity Read ↗

Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.Semantic proximity Read ↗

Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.